Thomas Freyman - Abbott Laboratories Insider

Abbott Laboratories -- Brazil Stock  

BRL 45.55  0.00  0.00%

Executive VP of Fin. and Admin.

Mr. Thomas C. Freyman is no longer Executive Vice President Finance and Administration of the Company effective February 1 2017. He was appointed to his current role in February 2004 and has served as Abbott Chief Financial Officer since 2001. Mr. Freyman joined Abbott in 1979 and has served in a number of financial planning and analysis positions. In 1984 Mr. Freyman was appointed Finance Director for Abbott European distribution center in the Netherlands. He also served as Division Controller Corporationrationrate Materials Management Vice President and Treasurer and Vice President and Controller Hospital Products Division. Prior to joining Abbott Mr. Freyman was a Certified Public Accountant with Ernst Whinney Chicago
Age: 60  EVP Since 2015      
224-667-6100  http://www.abbott.com
Freyman serves on the board of directors for the Chicago Botanic Garden. He is also a member of the Economic Club of Chicago, the Executives' Club of Chicago, the Healthcare Leadership Council and the S&P Corporationrationrationrate Ratings Issuer Council. He earned a Bachelor degree in Accounting from the University of Illinois and a Master degree in Management from Northwestern University.

Thomas Freyman Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.45 % which means that it generated profit of $3.45 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 4.05 % meaning that it generated $4.05 on every $100 dollars invested by stockholders.
The company has accumulated 24.09 B in total debt with debt to equity ratio (D/E) of 75.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbott Laboratories has Current Ratio of 2.88 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 1 records

EVP Since

Roberto DumaniCielo S A
2008

Entity Summary

Abbott Laboratories manufactures and sells health care solutions worldwide. Abbott Laboratories (ABTT34) is traded on Sao Paolo Stock Exchange in Brazil. It is located in Abbott Park, IL and employs 74,000 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Abbott Laboratories to your portfolio

Top Management

Abbott Laboratories Leadership Team
Scott White, President
Samuel Scott, Director
Deepak Nath, President
Jaime Contreras, President
Roger Bird, President
Nancy McKinstry, Director
Heather Mason, President
James Farrell, Director
J White, President
Phebe Novakovic, Director
JeanYves Pavee, President
Andrew Lane, President
Roxanne Austin, Director
Georges Vos, President
Stephen Fussell, President
Thomas Freyman, EVP
Sally Blount, Director
Daniel Starks, Director
Thomas Frinzi, President
Eric Fain, President
John Capek, EVP
Robert Alpern, Director, Ph.D
Murthy Simhambhatla, President
Miles White, Chairman
Robert Ford, President
Glenn Tilton, Director
Richard Ashley, EVP
Michael Rousseau, President
Edward Liddy, Director
Hubert Allen, EVP
Charles Foltz, President
Brian Yoor, CFO
John Stratton, Director
Joseph Manning, President
Jared Watkin, President
William Osborn, Director
Brian Blaser, EVP
Michael Warmuth, President
Robert Funck, President
Daniel Salvadori, President
W Farrell, Director

Stock Performance

Abbott Laboratories Performance Indicators